— Financial reporting — Consolidated statement of changes in equity
Consolidated statement of changes in equity
January 1 – December 31
|
|
|
|
|
Attributable to shareholders of medmix Ltd |
|
||||||||||
|
millions of CHF |
|
Notes |
|
Share capital |
|
Retained earnings |
|
Treasury shares |
|
Cash flow hedge reserve |
|
Currency translation adjustment |
|
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity as of January 1, 2020 |
|
|
|
– |
|
303.7 |
|
– |
|
–0.0 |
|
–8.6 |
|
295.1 |
|
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
9.6 |
|
|
|
|
|
|
|
9.6 |
|
|
– Cash flow hedges, net of tax |
|
26 |
|
– |
|
– |
|
– |
|
0.0 |
|
– |
|
0.0 |
|
|
– Remeasurements of defined benefit plans, net of tax |
|
8 |
|
– |
|
2.5 |
|
– |
|
– |
|
– |
|
2.5 |
|
|
– Currency translation differences |
|
|
|
– |
|
– |
|
– |
|
– |
|
–3.7 |
|
–3.7 |
|
|
Other comprehensive income |
|
|
|
– |
|
2.5 |
|
– |
|
0.0 |
|
–3.7 |
|
–1.1 |
|
|
Total comprehensive income for the period |
|
|
|
– |
|
12.1 |
|
– |
|
0.0 |
|
–3.7 |
|
8.5 |
|
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution from the Sulzer group |
|
4, 21 |
|
– |
|
81.4 |
|
– |
|
– |
|
– |
|
81.4 |
|
|
Share-based payments |
|
28 |
|
– |
|
0.5 |
|
– |
|
– |
|
– |
|
0.5 |
|
|
Dividends |
|
21 |
|
– |
|
–52.0 |
|
– |
|
– |
|
– |
|
–52.0 |
|
|
Equity as of December 31, 2020 |
|
21 |
|
– |
|
345.7 |
|
– |
|
– |
|
–12.3 |
|
333.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity as of January 1, 2021 |
|
|
|
– |
|
345.7 |
|
– |
|
– |
|
–12.3 |
|
333.4 |
|
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
44.0 |
|
|
|
|
|
|
|
44.0 |
|
|
– Cash flow hedges, net of tax |
|
26 |
|
– |
|
– |
|
– |
|
–0.6 |
|
– |
|
–0.6 |
|
|
– Remeasurements of defined benefit plans, net of tax |
|
8 |
|
– |
|
12.9 |
|
– |
|
– |
|
– |
|
12.9 |
|
|
– Currency translation differences |
|
|
|
– |
|
– |
|
– |
|
– |
|
0.1 |
|
0.1 |
|
|
Other comprehensive income |
|
|
|
– |
|
12.9 |
|
– |
|
–0.6 |
|
0.1 |
|
12.4 |
|
|
Total comprehensive income for the period |
|
|
|
– |
|
56.9 |
|
– |
|
–0.6 |
|
0.1 |
|
56.4 |
|
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution to the Sulzer group |
|
21 |
|
0.3 |
|
–104.5 |
|
– |
|
– |
|
– |
|
–104.1 |
|
|
Capital increase |
|
21 |
|
0.1 |
|
294.7 |
|
– |
|
– |
|
– |
|
294.7 |
|
|
Purchase of treasury shares |
|
21 |
|
– |
|
– |
|
–6.5 |
|
– |
|
– |
|
–6.5 |
|
|
Share-based payments |
|
28 |
|
– |
|
1.1 |
|
– |
|
– |
|
– |
|
1.1 |
|
|
Dividends |
|
21 |
|
– |
|
–41.3 |
|
– |
|
– |
|
– |
|
–41.3 |
|
|
Equity as of December 31, 2021 |
|
21 |
|
0.4 |
|
552.8 |
|
–6.5 |
|
–0.6 |
|
–12.2 |
|
533.9 |
|